Clinical Trial Update: Insulin, Neurogenetics and Memory in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for insulin-related neurogenetics approach in Alzheimer's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED